Dexamethasone treatment and fluid balance in preterm infants at risk for chronic lung disease

A F Bos1, W A van Asselt, A Okken

  • 1Division of Neonatology, Beatrix Children's Hospital, Groningen, The Netherlands. a.f.bos@med.rug.nl

Insights

Dexamethasone treatment in preterm infants significantly increases urine output 48-96 hours after initiation. This effect may be due to increased arterial pressure and elevated serum urea levels, necessitating careful fluid balance monitoring.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pharmacology
  • Nephrology

Background:

  • Dexamethasone is used in preterm infants, but its effect on diuresis is not well understood.
  • Preterm infants are at risk for chronic lung disease, a condition often managed with corticosteroids.

Purpose of the Study:

  • To investigate the influence of dexamethasone on urine output in preterm infants.
  • To identify potential mechanisms behind dexamethasone-induced changes in diuresis.

Main Methods:

  • A study involving 15 preterm infants (26-29 weeks gestational age) at risk for chronic lung disease.
  • Measurement of urine output, blood glucose, serum urea, creatinine, electrolytes, and arterial pressure before and during 4 days of intravenous dexamethasone treatment (0.25 mg/kg twice daily).

Main Results:

  • A significant increase in diuresis (30 ml/kg/day) was observed 48-96 hours after starting dexamethasone.
  • Concurrent increases in serum urea levels and arterial pressure were noted, while blood glucose and serum creatinine remained unchanged.
  • Fluid and protein intake were kept constant throughout the study.

Conclusions:

  • Dexamethasone administration leads to a significant increase in diuresis in preterm infants.
  • The diuresis is likely caused by pressure diuresis and increased osmolar load from elevated serum urea.
  • Close monitoring of fluid balance is recommended during the initial days of dexamethasone therapy in preterm infants.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Disorder of Water Balance01:29

Disorder of Water Balance

Water balance disorders are medical conditions that occur when there is a deviation from the body's water volume or osmolarity, disrupting normal homeostasis and leading todehydration, hypotonic hydration, hyperhydration, edema, or water intoxication.
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...